Inactive Instrument

Press Releases DICE THER

Equities

DICE

US23345J1043

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

Lilly Completes Acquisition of DICE Therapeutics	23-08-09	PR
Lilly Announces Extension of Tender Offer to Acquire DICE	23-07-25	PR
DICE THERAPEUTICS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of DICE Therapeutics, Inc. - DICE	23-07-10	BU
DICE THERAPEUTICS INVESTOR ALERT By the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of DICE Therapeutics, Inc. - DICE	23-06-21	BU
Shareholder Alert: Ademi LLP investigates whether DICE Therapeutics, Inc. has obtained a Fair Price in its transaction with Eli Lilly and Company	23-06-20	PR
DICE Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of DICE Therapeutics, Inc. Is Fair to Shareholders	23-06-20	BU
Lilly to Acquire DICE Therapeutics to Advance Innovation in Immunology	23-06-20	PR
DICE Therapeutics to Host R&D Investor Event on Tuesday, June 20, 2023	23-06-13	GL
DICE Therapeutics Reports First Quarter 2023 Financial Results and Recent Highlights	23-05-11	GL
DICE Therapeutics to Participate in the Bank of America Securities 2023 Healthcare Conference	23-05-03	GL
DICE Therapeutics to Participate in the Bank of America Securities 2023 Healthcare Conference	23-05-03	AQ
DICE Therapeutics : Corporate Presentation April 2023	23-04-05	PU
DICE Therapeutics to Participate in the H.C. Wainwright Autoimmune & Inflammatory Disease Virtual Conference	23-03-23	GL
DICE Therapeutics to Participate in the H.C. Wainwright Autoimmune & Inflammatory Disease Virtual Conference	23-03-23	GL
DICE Therapeutics : Corporate Presentation March 2023	23-03-15	PU
DICE THERAPEUTICS, INC. Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-K)	23-03-15	AQ
DICE Therapeutics Reports Fourth Quarter and Full Year 2022 Financial Results and Recent Highlights	23-03-15	GL
DICE Therapeutics Announces Late-Breaking Presentation at the 2023 American Academy of Dermatology (AAD) Annual Meeting	23-03-01	GL
DICE THERAPEUTICS, INC. : Change in Directors or Principal Officers (form 8-K)	23-02-10	AQ
DICE Therapeutics to Participate at Upcoming Investor Conferences	23-02-08	GL

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases DICE THER

Equities

DICE

US23345J1043

Press Releases

Filters